Application Nr Approved Date Route Status External Links
ANDA070101 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Disopyramide Phosphate Is Indicated For The Treatment Of Documented Ventricular Arrhythmias Such As Sustained Ventricular Tachycardia, That, In The Judgment Of The Physician, Are Life-Threatening. Because Of The Proarrhythmic Effects Of Disopyramide Phosphate, Its Use With Lesser Arrhythmias Is Generally Not Recommended. Treatment Of Patients With Asymptomatic Ventricular Premature Contractions Should Be Avoided. Initiation Of Disopyramide Phosphate Treatment, As With Other Antiarrhythmic Agents Used To Treat Life-Threatening Arrhythmias, Should Be Carried Out In The Hospital. Antiarrhythmic Drugs Have Not Been Shown To Enhance Survival In Patients With Ventricular Arrhythmias.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Disopyramide Phosphate DISOPYRAMIDE PHOSPHATE ZINC1530617

Comments